Cytomegalovirus Infection
23 drugs26,873 FAERS reportsMedDRA PT
GET
/api/v1/reaction/cytomegalovirus-infectionReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D003586
Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.
Source: U.S. National Library of Medicine — MeSH (Cytomegalovirus Infections)
Drugs reporting Cytomegalovirus Infection (23)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Ganciclovir1,25612%
- 2Treosulfan25910%
- 3Foscarnet39010.0%
- 4Valganciclovir1,7959.7%
- 5Basiliximab9047.9%
- 6Maribavir1807.7%
- 7Narsoplimab17.1%
- 8Brincidofovir96.6%
- 9Cidofovir896.4%
- 10Letermovir1705.7%
- 11Thiotepa5235.6%
- 12Busulfan9795.4%
- 13Alemtuzumab8404.4%
- 14Fludarabine1,6554.3%
- 15Belatacept1773.9%
- 16Mycophenolate4,8213.7%
- 17Mycophenolate Mofetil4,8213.7%
- 18Tacrolimus4,5613.0%
- 19Epcoritamab332.8%
- 20Sirolimus3402.6%
- 21Elranatamab232.6%
- 22Mycophenolic Acid8062.6%
- 23Cyclosporine2,2412.0%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Cytomegalovirus Infection Reactivation12 shared · 0.52
- Cytomegalovirus Viraemia8 shared · 0.35
- Transplant Rejection8 shared · 0.32
- Thrombotic Microangiopathy7 shared · 0.30
- Acute Graft Versus Host Disease In Skin5 shared · 0.22
- Cystitis Haemorrhagic4 shared · 0.17
- Adenovirus Infection4 shared · 0.15
- Acute Graft Versus Host Disease4 shared · 0.15
- Graft Versus Host Disease4 shared · 0.14
- Nephropathy Toxic4 shared · 0.14
Literature
Recent PubMed references pinned to Cytomegalovirus Infections as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Transfusion-transmitted cytomegalovirus infection in the era of universal leukoreduction and pathogen inactivation: a contemporary review.Laboratory medicine · 2026 · Kirupanantha Rajan P, Selvaraj S, Kirupanantha Rajan I, et al.PMID 42202041DOI 10.1093/labmed/lmag031
- Beyond CD4: Posterior segment findings and virologic-immunologic predictors in highly active antiretroviral therapy-naïve HIV patients.Indian journal of ophthalmology · 2026 · Hayat SC, Yilmaz YC, Gunduz A, et al.PMID 42200741DOI 10.4103/IJO.IJO_1957_25
- A Potent Inhibitor of Human Cytomegalovirus Infection Works Post-Entry Specifically in Differentiating Myelo-Monocytic Cells.Pathogens (Basel, Switzerland) · 2026 · Murray MJ, Hargreaves A, Bradley E, et al.PMID 42198647DOI 10.3390/pathogens15050520
- Clinical Characteristics and Outcomes of Cytomegalovirus DNAemia in Non-HIV-Infected and Non-Transplant Patients: A Propensity Score-Matched Analysis.Pathogens (Basel, Switzerland) · 2026 · Salter I, Corbisiero MF, Chastain DB, et al.PMID 42198618DOI 10.3390/pathogens15050492
- The risk of venous thromboembolism in kidney transplant recipients is enhanced following a cytomegalovirus infection.Frontiers in immunology · 2026 · Masset C, Lorent M, Le Borgne F, et al.PMID 42183266DOI 10.3389/fimmu.2026.1816608
- Artesunate repurposing for cytomegalovirus management: a systematic review of efficacy, mechanisms, and perspectives.Frontiers in cellular and infection microbiology · 2026 · Zhang H, Zhou F, Song J, et al.PMID 42180246DOI 10.3389/fcimb.2026.1815679
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.